Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α Inhibition
- PMID: 26181790
- DOI: 10.1227/01.neu.0000467297.56504.5b
Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α Inhibition
Comment on
-
The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.Clin Cancer Res. 2015 Jul 15;21(14):3274-85. doi: 10.1158/1078-0432.CCR-14-3118. Epub 2015 Mar 31. Clin Cancer Res. 2015. PMID: 25829396 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical